Related Experiment Videos
Hypozincemia in diabetes mellitus
The Journal of the Association of Physicians of India
|September 1, 1994
Summary
This study found significantly lower serum zinc levels in patients with diabetes mellitus compared to healthy individuals. These findings suggest a potential role for zinc in diabetes management and therapy.
Area of Science:
- Biochemistry
- Endocrinology
- Nutritional Science
Background:
- Diabetes mellitus is a global health concern associated with numerous metabolic complications.
- Zinc is an essential trace element involved in glucose metabolism and insulin action.
- Altered zinc homeostasis has been implicated in the pathophysiology of diabetes.
Purpose of the Study:
- To investigate serum zinc levels in patients with diabetes mellitus.
- To compare zinc levels between diabetic patients and healthy controls.
- To explore the potential implications of zinc deficiency in diabetes.
Main Methods:
- Serum samples were collected from 30 patients with diabetes mellitus and 20 age- and sex-matched healthy controls.
- Serum zinc concentrations were measured using a standard laboratory assay.
- Statistical analysis was performed to compare zinc levels between groups.
Main Results:
- Serum zinc levels were significantly reduced in diabetic patients compared to healthy controls (p < 0.001).
- No significant sex-based differences in serum zinc levels were observed in either group (P > 0.05).
- The results indicate a strong association between diabetes mellitus and hypozincemia.
Conclusions:
- Hypozincemia is a common finding in diabetes mellitus, potentially linked to altered zinc metabolism.
- Oral zinc supplementation may represent a therapeutic strategy for managing diabetes.
- Further research is warranted to elucidate the precise mechanisms and clinical benefits of zinc therapy in diabetes.